These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. [Clinical effect of L-DOPA and electromyographic study of Parkinsonism]. Sato G; Ito H; Handa Y; Takahashi I; Iijima K No To Shinkei; 1971 Mar; 23(3):325-32. PubMed ID: 5107821 [No Abstract] [Full Text] [Related]
31. Pyridoxine and levodopa in the treatment of Parkinsonism. Yahr MD; Duvoisin RC JAMA; 1972 May; 220(6):861. PubMed ID: 5067358 [No Abstract] [Full Text] [Related]
33. [Treatment of Parkinson's syndrome with L-dopa]. Kaeser HE; Ferel D; Wurmser P Schweiz Med Wochenschr; 1970 May; 100(19):805-13. PubMed ID: 4924276 [No Abstract] [Full Text] [Related]
34. [Confusional and oneiric episode after sudden withdrawal of L-dopa. Spontaneous resolution. Induced reproduction of such an episode]. Argenta G; Decina P; Pisani RA Riv Neurol; 1971; 41(2):112-8. PubMed ID: 5126428 [No Abstract] [Full Text] [Related]
35. Defective release of growth hormone in parkinsonism improved by levodopa. Mena I; Cotzias GC; Brown FC; Papavasiliou PS; Miller ST N Engl J Med; 1973 Feb; 288(6):320-1. PubMed ID: 4682676 [No Abstract] [Full Text] [Related]
36. Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism. Brogden RN; Speight TM; Avery GS Drugs; 1971; 2(4):262-400. PubMed ID: 4340597 [No Abstract] [Full Text] [Related]
38. Analysis of deaths in Parkinson patients on long-term levodopa therapy. Cote L; Yahr MD; Duvoisin RC; Wolf A; Marksbery W Trans Am Neurol Assoc; 1970; 95():73-7. PubMed ID: 4998770 [No Abstract] [Full Text] [Related]
39. Gout while receiving levodopa for Parkinsonism. Honda H; Gindin RA JAMA; 1972 Jan; 219(1):55-7. PubMed ID: 5066588 [No Abstract] [Full Text] [Related]